Kurt Griffin

3.3k total citations · 1 hit paper
27 papers, 1.1k citations indexed

About

Kurt Griffin is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Kurt Griffin has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Kurt Griffin's work include Cardiac tumors and thrombi (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Diabetes Management and Research (4 papers). Kurt Griffin is often cited by papers focused on Cardiac tumors and thrombi (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Diabetes Management and Research (4 papers). Kurt Griffin collaborates with scholars based in United States, Germany and Cameroon. Kurt Griffin's co-authors include Constantine A. Stratakis, Ioannis Bossis, Michael Gottschalk, Meg Keil, Jennifer Kyllo, Alex Rabinovitch, Paul A. Thompson, Audrey Robinson‐White, Dalia L. Batista and Edward H. Oldfield and has published in prestigious journals such as Journal of Biological Chemistry, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Kurt Griffin

27 papers receiving 1.0k citations

Hit Papers

Screening for Type 1 Diabetes in the General Population: ... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective
    2022 117 citations Emily K. Sims, Rachel Besser et al. Diabetes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Griffin United States 16 459 368 243 238 210 27 1.1k
Ralph Telgmann Germany 16 207 0.5× 122 0.3× 72 0.3× 315 1.3× 99 0.5× 30 1.2k
Pierre Lecomte France 18 770 1.7× 571 1.6× 25 0.1× 233 1.0× 30 0.1× 26 1.3k
S. Variend United Kingdom 20 47 0.1× 137 0.4× 78 0.3× 426 1.8× 118 0.6× 49 1.2k
Koichi Yano Japan 17 186 0.4× 191 0.5× 17 0.1× 276 1.2× 176 0.8× 80 946
Ke‐ita Tatsumi Japan 14 511 1.1× 86 0.2× 56 0.2× 264 1.1× 30 0.1× 26 932
Alexander Wehr Germany 8 95 0.2× 116 0.3× 29 0.1× 159 0.7× 114 0.5× 10 993
R Booth United States 12 283 0.6× 273 0.7× 59 0.2× 219 0.9× 67 0.3× 32 1.1k
Praveen Sharma India 18 96 0.2× 162 0.4× 17 0.1× 196 0.8× 301 1.4× 87 1.1k
Marte K. Viken Norway 20 56 0.1× 96 0.3× 31 0.1× 339 1.4× 91 0.4× 50 1.3k
Katrin Horn Germany 15 76 0.2× 62 0.2× 38 0.2× 178 0.7× 34 0.2× 32 596

Countries citing papers authored by Kurt Griffin

Since Specialization
Citations

This map shows the geographic impact of Kurt Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Griffin more than expected).

Fields of papers citing papers by Kurt Griffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Griffin. The network helps show where Kurt Griffin may publish in the future.

Co-authorship network of co-authors of Kurt Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Griffin. A scholar is included among the top collaborators of Kurt Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Griffin. Kurt Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Besser, Rachel & Kurt Griffin. (2024). Transitioning to stage 3 type 1 diabetes: when to start insulin. The Lancet Diabetes & Endocrinology. 12(10). 692–694. 4 indexed citations
2.
Patel, Neha, Ingrid Libman, Kimber M. Simmons, et al.. (2024). Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice. Hormone Research in Paediatrics. 98(5). 597–608. 4 indexed citations
3.
Sims, Emily K., Rachel Besser, Colin Dayan, et al.. (2022). Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective. Diabetes. 71(4). 610–623. 117 indexed citations breakdown →
4.
Radichev, Ilian, Jeongheon Yoon, David W. Scott, Kurt Griffin, & Alexei Y. Savinov. (2020). Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor. Cellular Immunology. 358. 104224–104224. 28 indexed citations
5.
Narra, Hema P., Lisa F. Shubitz, M. Alejandra Mandel, et al.. (2016). A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection. Infection and Immunity. 84(10). 3007–3016. 45 indexed citations
6.
Griffin, Kurt, Paul A. Thompson, Michael Gottschalk, Jennifer Kyllo, & Alex Rabinovitch. (2014). Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial. The Lancet Diabetes & Endocrinology. 2(9). 710–718. 68 indexed citations
7.
Levin, Sondra W., Eva H. Baker, Wadih M. Zein, et al.. (2014). Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study. The Lancet Neurology. 13(8). 777–787. 58 indexed citations
8.
Wagner, April M, et al.. (2014). Elimination of Pasteurella pneumotropica from a mouse barrier facility by using a modified enrofloxacin treatment regimen.. PubMed. 53(5). 517–22. 10 indexed citations
9.
Perfect, Michelle M., et al.. (2011). Sleep, Glucose, and Daytime Functioning in Youth with Type 1 Diabetes. SLEEP. 35(1). 81–88. 99 indexed citations
10.
Almeida, Madson Q., Michael Muchow, Sosipatros A. Boikos, et al.. (2010). Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/− or Rb1+/− backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling. Human Molecular Genetics. 19(8). 1387–1398. 47 indexed citations
11.
12.
Horvath, Anélia, Christoforos Giatzakis, Audrey Robinson‐White, et al.. (2006). Adrenal Hyperplasia and Adenomas Are Associated with Inhibition of Phosphodiesterase 11A in Carriers of PDE11A Sequence Variants That Are Frequent in the Population. Cancer Research. 66(24). 11571–11575. 80 indexed citations
13.
Batista, Dalia L., et al.. (2005). Detection of Adrenocorticotropin-Secreting Pituitary Adenomas by Magnetic Resonance Imaging in Children and Adolescents with Cushing Disease. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5134–5140. 84 indexed citations
14.
Griffin, Kurt, Lawrence S. Kirschner, Ludmila Matyakhina, et al.. (2004). Down-Regulation of Regulatory Subunit Type 1A of Protein Kinase A Leads to Endocrine and Other Tumors. Cancer Research. 64(24). 8811–8815. 78 indexed citations
15.
16.
Griffin, Kurt, Lawrence S. Kirschner, Ludmila Matyakhina, et al.. (2004). A Mouse Model for Carney Complex. Endocrine Research. 30(4). 903–911. 11 indexed citations
17.
Bossis, Ioannis, et al.. (2004). Protein kinase A and its role in human neoplasia: the Carney complex paradigm.. Endocrine Related Cancer. 11(2). 265–280. 70 indexed citations
18.
19.
Griffin, Kurt, et al.. (1989). The benzodiazepine receptor ligands RO 5-4864 and RO 15-1788 do not block the inhibition of PAF-induced platelet aggregation seen with the hetrazepine WEB2086. Biochemical and Biophysical Research Communications. 160(1). 263–267. 2 indexed citations
20.
Griffin, Kurt & Joseph V. Levy. (1988). The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). Thrombosis Research. 51(2). 219–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph Telgmann Breakdown of academic impact, for papers by Pierre Lecomte Breakdown of academic impact, for papers by S. Variend Breakdown of academic impact, for papers by Koichi Yano Breakdown of academic impact, for papers by Ke‐ita Tatsumi Breakdown of academic impact, for papers by Alexander Wehr Breakdown of academic impact, for papers by R Booth Breakdown of academic impact, for papers by Praveen Sharma Breakdown of academic impact, for papers by Marte K. Viken Breakdown of academic impact, for papers by Katrin Horn
Rankless by CCL
2026